20287 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS
#302SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS
#303Vitamin C composition for use in the prevention and treatment of stretch other skin conditions and methods of using the same
#304Compositions for the treatment of dry eye
#305PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#306Sulfonamide anti-viral compounds
#307PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#308Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereof
#309Polymorphs of darunavir
#310Novel Uses of Neuraminidase Inhibitors in Infectious Diseases
#311Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
#312Anti-radical agents
#313SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
#314Selective cytopheresis devices and related methods thereof
#315COMPOSITION AND METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULES
#316Pharmaceutical composition for the treatment of acute disorders
#317Pharmaceutical composition for the treatment of acute disorders
#318INTERFERON-INDUCING COMPOUNDS AND USES THEREOF
#319ESCITALOPRAM AND SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#320Amorphous darunavir
#321REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN
#322Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV)
#323Hemostatic dressing
#324Selective cytopheresis devices and related methods thereof
#325Degradable removable implant for the sustained release of an active compound
#326Synergistic Combination Therapy
#327BRCA1-based breast or ovarian cancer treatment agents and methods of use
#328Selective cytopheresis devices and related methods thereof
#329MODULATING LYMPHATIC FUNCTION
#330DIURETIC AND DIURETIC-LIKE COMPOUND ANALOGS
#331METHODS AND COMPOSITIONS FOR PROMOTING REGENERATION BY INCREASING INTRACELLULAR SODIUM CONCENTRATION
#332Synthetic lactone formulations and method of use
#333HYDROXYTYROSOL COMBINATIONS FOR ENHANCING MITOCHONDRIAL FUNCTION AND ENERGY PRODUCTION
#334VASODILATOR-ENHANCED CARDIOPULMONARY RESUSCITATION
#335Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
#336Therapeutic agent for mood disorders
#337Method of treating contrast-induced nephropathy
#338Antimicrobial Compositions
#339Methods of treating and preventing/reducing the likelihood of Mesial temporal lobe epilepsy (TLE)
#340Facially Amphiphilic Compounds, Compositions, And Uses Thereof In Treating Cancer
#341METHOD FOR THE TREATMENT AND PREVENTION OF ERECTILE DYSFUNCTION
#342Inhibitors of bacterial type III secretion system
#343METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
#344Cannabinoid Compositions and Methods
#345CONTROLLED RELEASE COMPOSITIONS COMPRISING A COMBINATION OF ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
#346Method and Formulation for Chemical Peeling
#347ORAL MEDICINAL COMPOSITION AND ORAL MEDICINAL CAPSULE HAVING THE COMPOSITION ENCAPSULATED THEREIN
#348Compositions For Treating Chronic Viral Infections
#349Hydroxamates as therapeutic agents
#3503-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
#351Soft capsule of butylphthalide and a process for preparing the same
#352Synergistic fungicidal and algicidal compositions including 2-hydroxyphenylaldehyde and 2-hydroxyphenylketone heterocycloyhydrazones and copper
#353Treatment for altitudinal hypoxia
#354POLYMORPHS OF DARUNAVIR
#355Cell Culture Media Supplement and Method of Molecular Stress Control
#356Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
#357METHODS AND COMPOSITIONS TO INHIBIT EDEMA FACTOR AND ADENYLYL CYCLASE
#358POLYMORPHS OF DARUNAVIR
#359GLP-1 receptor stabilizers and modulators
#360Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
#361HISTONE DEACETYLASE INHIBITORS
#362Nitrofuran compounds for the treatment of cancer and angiogenesis
#363Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
#364Polycyclic compounds and methods related thereto
#365ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE
#366Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols
#367COMPOSITIONS AND METHODS FOR REDUCING THE MUTATION RATE OF VIRUSES
#368Selective cytopheresis devices and related methods thereof
#369USE OF IMMUNOSUPPRESSANT COMPOUNDS IN A NEW INDICATION
#370CORTISTATIN ANALOGUES AND SYNTHESES THEREOF
#371GASTRORETENTIVE DRUG DELIVERY SYSTEM, PREPARATION METHOD AND USE THEREOF
#372VITAMIN C COMPOSITION FOR USE IN THE PREVENTION AND TREATMENT OF STRETCH MARKS, RADIATION DERMATITIS, AND OTHER SKIN CONDITIONS AND METHODS OF USING THE SAME
#373COMPOSITION AND METHOD
#374Dissolvable dietary supplement strip and methods for using the same
#375Bruise amelioration composition and method of use
#376COMPOUNDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES
#377Novel Uses of Neuraminidase Inhibitors in Infectious Diseasess
#378Bruise amelioration composition and method of use
#379Compositions and methods for improving skin appearance
#380HIV protease inhibitor and cytochrome p450 inhibitor combinations
#381Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide
#382Transdermal delivery of ionizable drugs
#383Phosphodiesterase 4 inhibitors
#384ANTIBIOTIC COMPOUNDS
#385Hydroxamates as therapeutic agents
#386Anti-retroviral combination
#387PTEN Inhibitors Treat Neutropenia-Associated Pneumonia
#388METHOD FOR TREATING AMYLOIDOSIS
#389Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
#390Escitalopram and solid pharmaceutical composition comprising the same
#391Inflammatory Disease Treatment
#392Small Molecule Intervention for Obesity
#393Selective cytopheresis devices and related methods
#394Selective cytopheresis devices and related methods thereof
#395Selective cytopheresis devices and related methods thereof
#396Selective cytopheresis devices and related methods thereof
#397Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same
#398EPH RECEPTOR LIGANDS AND METHODS OF USE
#399PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF RESTENOSIS
#400Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina
#401COMPOUND FOR TREATMENT OR PREVENTION OF PROSTATE-RELATED DISEASES AND PHARMACEUTICAL COMPOSITION OF COLON DELIVERY SYSTEM CONTAINING THE SAME
#402PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES INVOLVING IMPOTENCE
#403PHARMACEUTICAL COMPOSITION CONTAINING PHENANTHRENEQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM
#404NEW USE OF SPECIFIC CYKLOLIGNANS
#405Antioxidant Compositions, Beverage Formulations Thereof, and Methods of Increasing Antioxidant Capability
#406METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#407COMBINATION FORMULATIONS
#408RELATING TO ANTI-HIV TABLET FORMULATIONS
#409Biological therapeutic compositions and methods thereof
#410OCULOSELECTIVE DRUGS AND PRODRUGS
#411SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS
#412Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same
#413Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
#414Methods and compositions for treating HIV infections
#415Micronized Eplerenone Compositions
#416DUAL INHIBITION OF CYCLOOXYGENASE-2 AND CARBONIC ANHYDRASE
#417COMPOSITIONS FOR TREATING VASCULAR DISEASES CHARACTERIZED BY NITRIC OXIDE INSUFFICIENCY
#418o/w/o EMULSION CONTAINING LIGNAN COMPOUNDS AND COMPOSITION CONTAINING THE SAME
#419PHARMACEUTICAL COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM
#420COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AN DMETHODS FOR INHIBITING HIV INFECTIVITY
#421Methods for regulating cell mitosis by inhibiting serine/threonine phosphateses
#422Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
#423ENTERIC COATED HYDROPHOBIC MATRIX FORMULATION
#424Use of specific cyklolignans
#425Antimicrobial compositions
#426Solid Dosage Formulations of Hydralazine Compounds and Nitric Oxide Donor Compounds
#427GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF G-PROTEIN BETA 3 SUBUNIT POLYMORPHISM
#428Method of treatment for muscular dystrophy
#429Diamidine Inhibitors of TDP1
#430Methods and Compositions for the Treatment of Lupus Using Clofarabine
#431METHOD FOR IMPROVING CARDIOVASCULAR RISK PROFILE OF COX INHIBITORS
#432Protection of Oxidizable Agents
#433Bactericide composition
#434THERAPIES FOR COGNITION AND LEARNING ENHANCEMENT
#435Enhancing Disease Resistance In An Animal
#436Methods of treating vascular diseases characterized by nitric oxide insufficiency
#437Method of Treating An Acute Vascular Disorder
#438Hydroxamates as therapeutic agents
#439METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS
#440Ache-Nmda Combination Wafer
#441ANHYDROUS COMPOSITIONS USEFUL FOR ATTAINING ENHANCED SEXUAL WELLNESS
#442ORGANIC NANOPARTICLES AND METHOD OF PREPARATION THEREOF
#443GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF BETA 1 ADRENERGIC RECEPTOR GLY389ARG POLYMORPHISM
#444Composition for enhancing immunity and reducing inflammation related to infections
#445TREATMENT OF HEADACHES, NECK PAIN, JOINT PAIN AND INFLAMMATORY-TYPE PAIN
#446Inhibitors of cytochrome P450
#447BRCA1-BASED BREAST OR OVARIAN CANCER PREVENTION AGENTS AND METHODS OF USE
#448Compounds for the treatment of metabolic disorders
#449Methods and compositions for the treatment of autoimmune disorders using clofarabine
#450EPreceptor antagonists
#451Anticancer effect enhancer
#452Treatment with combined use of oxypurines and ascorbate to prevent and mitigate iron-catalized oxidative damage in Alzheimer's disease and other neurodegenerative disorders
#453Stimulation Of CPT-1 As A Means To Reduce Weight
#454Compositions and Methods for Treating Cancer
#455COMPOSITIONS AND METHODS RELATED TO HEART FAILURE
#456METHODS FOR REDUCING HOSPITALIZATIONS RELATED TO HEART FAILURE
#457Angelicae Sinensis Extracts Useful for Treatment of Cancers
#458Use of compounds for the prevention of drug-induced cell toxicity
#459Methods and compositions to inhibit edema factor and adenylyl cyclase
#460Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#461Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User
#462Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3
#463Selective cytopheresis devices and related methods thereof
#464COMPOSITIONS CONTAINING RIBOFLAVIN AND SESAMIN-CLASS COMPOUNDS
#465METHODS FOR TREATING RESPIRATORY DISORDERS
#466Pharmaceutical Compositions Containing Nitrovinylfuran Derivatives for the Treatment of Leishmaniosis and Trypanosomosis
#467Use of phosphatases to treat neuroblastomas and medulloblastomas
#468BRUISE AMELIORATION COMPOSITION AND METHOD OF USE
#469Antibacterial agents
#470Methods of restoring cognitive ability using non-peptidic compounds
#471Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
#472Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor
#473IMPROVED CARRIERS FOR DELIVERY OF NUCLEIC ACID AGENTS TO CELLS AND TISSUES
#474Butylphthalide self-emulsifying drug delivery system, its preparation and method and application
#475Enhancing Disease Resistance In An Animal
#476Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
#477Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina
#478Cosmetic compositions
#479BUTYLPHTHALIDE SOFT GEL CAPSULE AND ITS PREPARATION PROCEDURE
#480METHOD AND COMPOSITION FOR PROVIDING CONTROLLED DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES
#481Anti-Radical Agents
#482Methods Using Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate
#483Pharmaceutical composition for the treatment of acute disorders
#484Methods of preventing the serotonin syndrome and compositions for use thereof
#485Compositions and Methods for Treating Burns
#486Sesamin/Episesamin Compositions
#487Therapeutic Combinations for the Treatment or Prevention of Depression
#488Cancer therapy with cantharidin and cantharidin analogs
#489Modulating Lymphatic Function
#490Hydroxamates as therapeutic agents
#491Hydroxamates as therapeutic agents
#492Composition For Enhancing Immunity and Reducing Inflammation Related to Infections
#493Use of flibanserin in the treatment of obesity
#494KITS OF HYDRALAZINE COMPOUNDS AND ISOSORBIDE DINITRATE AND/OR ISOSORBIDE MONONITRATE
#495Use of specific cyklolignans
#496FURAN DERIVATIVES FOR PREVENTING AND CURING OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
#497Ex Vivo Gene Expression in Whole Blood as a Model of Assessment of Individual Variation to Dietary Supplements
#498Antimicrobial Compositions
#499NOVEL ASCORBIC ACID COMPOUNDS, METHODS OF SYNTHESIS AND APPLICATION USE THEREOF
#500Cosmetic composition comprising a lipid fraction from vegetable source and anticrystaling agent
#501USE OF ER-BETA SELECTIVE LIGANDS FOR TREATING ACUTE LUNG INJURIES
#502Solid oral formulations for combination therapy
#503METHOD OF TREATING OCULAR HYPERTENSION AND INTESTINAL DISORDERS BY USING DIANHYDROHEXITE MONONITRATE DERIVATIVES
#504Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
#505Control Of Feeding Behavior By Changing Neuronal Energy Balance
#506Use of specific cyklolignans
#507COMBINATION THERAPY FOR THE TREATMENT OF PAIN
#508Neuroprotectant methods, compositions, and screening methods thereof
#509USE OF BETA-ADRENOCEPTOR ANTAGONISTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISORDERS OF THE OUTER RETINA
#510Method of treating HIV infection
#511Solid oral formulations for combination therapy
#512Herbal composition for treating hangovers
#513Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#514RESTORATIVE SKIN CREAM
#515Anticancer Effect Enhancer
#516EPreceptor antagonists
#517Antiretroviral combination therapy
#518Cholesterol lowering drug combination
#519Pain relief composition
#520Treating sex steriod responsive disorders
#521Butylphtualide Soft Gel Capsule and Its Preperation Procedure
#522TOPICALLY APPLIED PROBUCOL-CONTAINING AGENT WITH PROTECTIVE AND REGENERATIVE EFFECT
#523Ultraviolet absorbing ophthalmic compositions
#524Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
#525Pharmacological treatment of cognitive impairment
#526Hydroxamates as therapeutic agents
#527NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS
#528Controlled release oxycodone compositions
#529DEVICES, METHODS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AGENTS FOR THE TREATMENT OF SINUSITIS, RHINITIS, AND OTHER DISORDERS
#530Sulfonated compounds and compositions for treating amyloidosis
#531Compositions and methods for treating cancer
#532Antimicrobial compositions
#533Oculoselective Drugs and Prodrugs
#534Treatment for Necrotizing Enterocolitis
#535Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
#536Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
#537Abnormal cannabidiols as agents for lowering intraocular pressure
#538Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
#539Anti-first-pass effect compounds
#540Nutrient supplements and methods for treating autism and for preventing the onset of autism
#541Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof
#542Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
#543Compounds that inhibit caspase activity for treating glaucoma
#544Compositions for the treatment and prevention of heart disease and methods of using same
#545Selenophene anti-tumor agents
#546Triptolide derivatives and their uses
#547Micronized Eplerenone Compositions
#548Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
#549Methods for treating blood disorders with nitric oxide donor compounds
#550Stable pharmaceutical compositions, processes for making the same and methods of their use
#5511-Oxadibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders
#552Biaryl linked hydroxamates: preparation and pharmaceutical applications
#553Cancer chemotherapy
#554Diuretic and diuretic-like compound analogs
#555Method for inhibiting cancer development by fatty acid synthase inhibitors
#556Angelicae sinensis extracts useful for treatment of cancers
#557Soft capsule of butylphthalide and a process for preparing the same
#558PHARMACEUTICAL FORMULATIONS CONTAINING 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(2-HYDROXYETHYL)(METHYLSULFONYL)AMINO]-N-METHYL-1-BENZOFURAN-3-CARBOXAMIDE AND METHOD OF MAKING THE SAME
#559EPreceptor antagonists
#560Method of treating diseases involving non-enzymatic glycation
#561Direct application of vitamin C to the lung tissue and respiratory passages by use of an asthma medication-type inhaler or similar inhaler
#562Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride
#563Stimulation of CPT-1 as a means to reduce weight
#564HIV protease inhibitors
#565Phosphodiesterase 4 inhibitors
#566Regulation of T cell-mediated immunity by tryptophan
#567Regulation of T cell-mediated immunity by tryptophan
#568Phenylethylamine analogs and their use for treating glaucoma
#569Substituted 2-aminotetralin for the treatment of depression
#570Methods and compositions for phosphate binding
#571Histone deacetylase inhibitors
#572Substituted phenylsulfonamide inhibitors of beta amyloid production
#573Pharmaceutical composition for the treatment of acute disorders
#574Nutrient supplements and methods for treating autism and for preventing the onset of autism
#575Ubiquitin ligase inhibitors and methods related thereto
#576Dihydrobenzofuran derivatives and uses therof
#577Therapeutic combinations for the treatment or prevention of depression
#578Treatment of pain
#579Hypoallergenic Flavor Compositions and Packages, and Methods of Managing Allergic Reactions in Pets
#580Uses of neuraminidase inhibitors in infectious diseases
#581Calcium receptor-active molecules
#582Novel hydroxylated enantiomers of (-) 3a,6,6,9a-tetramethylperhydronaphtho[2,1-b]furan as perfuming agents derived from a fungal fermentation process.
#583Methods and compositions for specific inhibition of protein splicing by small molecules
#584Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
#585C10 cyclopropyl ester substituted taxane compositions
#586Method for treating depression and/or anxiety
#587Use of a plant extract
#588Method for treating amyloidosis
#589Use of cyclolignans and new cyclolignans
#590Combination of a glycine transporter (GLYT1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof
#591Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide
#592Compounds, pharmaceutical compositions and methods for inhibiting HIV infectivity
#593Anti-microbial agents derived from methionine sulfoximine analogues
#594Comprehensive pharmacologic therapy for treatment of obesity
#595Method for treating HIV infection through co-administration of tipranavir and darunavir
#596Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
#597Methods and compositions for the treatment of lupus using clofarabine
#598Method and composition for resuscitation
#599Method and composition for resuscitation
#600Novel pharmacophore for the discovery and testing of na,k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions